About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Next-Gen MS: Feed-forward PRO Data for MS Research

Next-Gen MS: Feed-forward PRO Data for MS Research

NCT04907305·8 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

EMD Serono Research & Development Institute, Inc.

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Participants willing and able to provide written informed consent
Participants with clinical diagnosis of Multiple Sclerosis (MS)

You may not be if

None

The record

StatusTerminated

PhaseNo phase

Taking part1,594

StartedNov 2021

UpdatedJun 6, 2024

Conditions

Multiple Sclerosis (MS)

Where8

Alabama Neurology Associates
Birmingham, Alabama, United States
Georgetown University
Washington D.C., District of Columbia, United States
Atlanta Neuroscience Institute
Atlanta, Georgia, United States